Table 3.
Clinical outcomes by AKI status (n=2025)
| Factor | AKI | P value§ | AKI Stage | P value§ | ||||
|---|---|---|---|---|---|---|---|---|
| AKI N (%) (n=396) | No AKI N (%) (n=1629) | 0 N (%) (n=1629) | 1 N (%) (n=183) | 2 N (%) (n=105) | 3 N (%) (n=108) | |||
| Mortality | ||||||||
| Non-survival | 122 (30.8) | 97 (06.0) | < 0.001** | 97 (06.0%) | 42 (23.0) | 27 (25.7) | 53 (49.1) | < 0.001** |
| Survival | 274 (69.2) | 1532 (94.0) | 1532 (94.0) | 141 (77.0) | 78 (74.3) | 55 (50.9) | ||
| Extended LOS | 156 (39.4) | 339 (20.8) | < 0.001** | 339 (20.8) | 72 (39.3) | 41 (39.0) | 43 (39.8) | < 0.001** |
| Dopamine | 182 (46.0) | 209 (12.8) | < 0.001** | 209 (12.8) | 65 (35.5) | 56 (53.3) | 61 (56.5) | < 0.001** |
| Caffeine | ||||||||
| GA ≥ 29 weeks | 45 (32.8) | 276 (28.8) | 0.335 | 276 (28.8) | 27 (38.0) | 09 (31.0) | 09 (24.3) | 0.363 |
| GA < 29 weeks | 115 (85.2) | 206 (92.0) | 0.043** | 206 (92.0) | 56 (84.8) | 37 (86.0) | 22 (84.6) | 0.247 |
AKI Acute Kidney Injury; LOS Length of Hospital Stay
§P value has been calculated using the Chi square test
**Significant at P < 0.05 level